Autoimmune Disease Diagnostics: Global Markets

Sep 2021| PHM160B| BCC Publishing
Sample Report

Report Highlights

The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.

Report Includes

  • 37 data tables and 33 additional tables
  • An overview of the global market for autoimmune disease diagnostics
  • Estimation of the market size and analyses of the global market trends, with data from 2019, 2020 estimates for 2021 with projection of CAGR through 2026
  • Market share analysis of autoimmune disease diagnostics based on technology, indication, region and gender and identification of new opportunities, challenges, and technological changes within the industry
  • Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
  • Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
  • Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
  • Detailed analysis of the current market trends, market forecast, and discussion of technological, and regulatory elements that are affecting the future marketplace
  • Comprehensive company profiles of major players in the industry, including Biomerieux, Thermo Fisher Scientific, Siemens Healthcare Diagnostics, Beckman Coulter, Becton Dickinson  and Abbott

Report Scope

The report will provide details about autoimmune disease diagnostics used in the treatment of autoimmune disease and how the market has been influenced by the pandemic of COVID-19. This report will also highlight the current and future market potential of autoimmune disease diagnostics with detailed analyses of the competitive environments between companies. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence autoimmune disease and regulatory scenarios will also be covered. The report includes a market projection for 2026 and market shares for key players.

The report segments the market for autoimmune disease diagnostics based on technology, gender, indications and geography. Based on technology, the market is segmented into indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), ImmunoBlot, multiplex immunoassays and others. Based on indications, the market is segmented into type 1 diabetes, rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus (SLE), and others (pernicious anemia, celiac disease, autoimmune vasculitis, myasthenia gravis, Hashimoto’s thyroiditis, Sjögren’s syndrome, Graves’ disease, Addison’s disease, etc.). Based on gender, the market is segmented into male and female.

By geography, the market has been segmented into North America, Europe, the Asia-Pacific and the Rest of the World. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, the Gulf Cooperation Council countries and South Africa will be covered in the regional segments. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast values for 2026.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Autoimmune Disease Diagnostics: Global Markets223 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background20$495Free
Chapter- 4: Market Dynamics13$322Free
Chapter- 5: Market Breakdown by Gender8$198Free
Chapter- 6: Market Breakdown by Technology35$867Free
Chapter- 7: Market Breakdown by Indication24$595Free
Chapter- 8: Market Breakdown by Region44$1,090Free
Chapter- 9: Impact of COVID-19 on Autoimmune Disease Diagnostics Market8$198Free
Chapter- 10: Value Chain Analysis10$248Free
Chapter- 11: Regulatory Scenario5$124Free
Chapter- 12: Competitive Landscape8$198Free
Chapter- 13: Company Profiles37$917Free
Chapter- 14: Appendix: Acronyms1$25Free
Published - Sep-2014| Analyst - Anandi Karumbati| Code - PHM160A

Report Highlights

The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.

Report Includes

  • An overview of the global market for autoimmune disease diagnostics.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Segmentation of the market by disease, by geographical location, and by gender.
  • Industry analysis with focuses on customers, suppliers, competitors, new entrants, substitutes, and complements.
  • Comprehensive company profiles of major players in the industry.

Autoimmune Disease Diagnostics: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.